What is Wandercraft?
Founded in 2012, Wandercraft is a Parisian medtech company dedicated to restoring mobility through cutting-edge robotics. The company's flagship product, Atalante, is a self-balancing exoskeleton featuring 12 degrees of freedom, designed to assist users in walking through real-time gait analysis and robotic support. By integrating advanced software with mechanical engineering, Wandercraft occupies a unique position at the intersection of healthcare and robotics, aiming to redefine the standards of rehabilitation and personal mobility for patients worldwide.
How much funding has Wandercraft raised?
Wandercraft has raised a total of $150.5M across 6 funding rounds:
Other Financing Round
$91K
Angel/Seed
$908K
Series A
$4.5M
Series B
$25M
Series C
$45M
Series D
$75M
Other Financing Round (2013): $91K with participation from Wilco
Angel/Seed (2013): $908K led by Anaxago, Kima Ventures, and Wilco
Series A (2015): $4.5M supported by Innovation Capital and Anaxago
Series B (2017): $25M featuring XAnge, Anaxago, Idinvest Partners, Innovation Capital, Cemag Invest, and Bpifrance
Series C (2022): $45M backed by AG2R The World, Bpifrance, Macsf, Quadrant Management, and Malakoff Humanis
Series D (2025): $75M with participation from Bpifrance, Teampact.ventures, LBO France, Groupe Renault, and European Investment Bank
Key Investors in Wandercraft
Bpifrance
A French public investment bank that provides credit, guarantees, and equity to support innovation and international growth for companies at every stage of development.
Anaxago
A prominent crowdfunding platform that democratizes access to private equity and real estate investments for both private and professional investors.
Groupe Renault
A leading multinational automotive manufacturer that invests in sustainable mobility solutions and advanced technologies to drive the future of transportation.
What's next for Wandercraft?
With the successful closure of this Series D round, Wandercraft is poised to scale its manufacturing capabilities and expand its international footprint. The strategic involvement of major institutional backers and industry partners suggests a focus on clinical validation and the integration of its technology into mainstream healthcare systems. Future growth will likely center on enhancing the Atalante platform's algorithmic precision and exploring new applications for its proprietary robotic assistance technology, ensuring the company remains at the forefront of the global assistive robotics market.
See full Wandercraft company page
